Status:

NOT_YET_RECRUITING

Validity and Reliability of the 6-Minute Pegboard and Ring Test in Patients With Coronary Artery Disease

Lead Sponsor:

Gazi University

Conditions:

Coronary Artery Disease (CAD)

Eligibility:

All Genders

18-85 years

Brief Summary

Coronary artery disease, a cardiovascular disease, causes significant mortality and morbidity. Due to the impairment of arterial blood flow in coronary artery disease, the heart muscle cannot receive ...

Detailed Description

Coronary artery disease, a cardiovascular disease, causes significant mortality and morbidity. Due to the impairment of arterial blood flow in coronary artery disease, the heart muscle cannot receive ...

Eligibility Criteria

Inclusion

  • Individuals diagnosed with coronary artery disease by conventional angiography or computed tomography coronary angiography,
  • Clinically stable,
  • Ages between 18 and 85,
  • Volunteering to participate in the study will be included in the study.

Exclusion

  • Individuals diagnosed with heart failure,
  • Those diagnosed with moderate-to-severe valvular disease,
  • Those with a history of orthopedic, neurological, or pulmonary disease that could affect exercise testing and exercise capacity,
  • Those with contraindications to exercise testing according to the American College of Sports Medicine (ACSM) criteria,
  • Those with a history of coronary artery bypass surgery will not be included in the study.

Key Trial Info

Start Date :

September 15 2025

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

September 25 2026

Estimated Enrollment :

32 Patients enrolled

Trial Details

Trial ID

NCT07163741

Start Date

September 15 2025

End Date

September 25 2026

Last Update

September 9 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Gazi University Faculty of Health Sciences Department of Cardiopulmonary Physiotherapy and Rehabilitation, Ankara, Çankaya 06490

Ankara, Turkey (Türkiye)